Drospirenone/estetrol, sold under the brand name Nextstellis among others, is a fixed-dose combination medication containing drospirenone, a progestin, and estetrol, an estrogen, which is used as a combined birth control pill for the prevention of pregnancy in women. It is taken by mouth.
It was approved for medical use in Canada in March 2021, and in the United States in April 2021.[4...
* May have multiple approval dates, manufacturers, or labelers.